The FDA has approved its first at-home collection kit that allows women to screen themselves for human papillomavirus (HPV) and cervical cancer risk by mailing a sample to a lab—where it is analyzed by the same Pap smear test used in clinics.
Developed by Teal Health, the Teal Wand is available with a prescription. It uses a spongelike swab to gather a sample from within the vagina, with no speculum required.
According to a study conducted by the company that included more than 600 participants, samples collected with the Teal Wand were shown to be just as accurate as those taken by a clinician during an office visit—and much more preferable. About 94% of participants said they would opt for self-collection in the future, and 86% said they felt they would be more likely to stay up to date with cervical cancer screening if they could do it at…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
Join CBSA for Diversity, Equity, and Inclusion Workshops in June + July
CBSA is committed to advancing Diversity, Equity, and Inclusion (DEI) in Colorado’s life sciences community to help everyone find their place in our life sciences ecosystem, build diverse and inclusive organizations, and better serve diverse […]
Heart Disease Risks in Women Often Rise During the Years Right Before Menopause
Many heart disease symptoms that are typically associated with menopause actually begin before that milestone is reached – during perimenopause. This is the stage, generally in women’s 40s, when they are transitioning into menopause. Click […]
28-year-old community clinic plans expansion that will triple number of patients
Focused on Denver’s Latino community, Tepeyac projects thousands more will use the new clinic. Click here to view original post
